News on Medial

Related News

Exclusive: Grapevine set to raise Series A led by Kae Capital

EntrackrEntrackr · 1m ago
Exclusive: Grapevine set to raise Series A led by Kae Capital
Medial

**Exclusive: Grapevine set to raise Series A led by Kae Capital** Anonymous social media platform Grapevine is set to raise Rs 33.86 crore (around $3.8 million) in its Series A round, led by Kae Capital, with participation from Peak XV Partners and Unilazer Ventures. According to the company’s latest regulatory filing with the Registrar of Companies (RoC), the board has approved a special resolution to issue 44,325 Series A preference shares at a price of Rs 7,599.5 per share, to raise the aforementioned amount. As per the filing, Kae Capital will invest Rs 18 crore, while Peak XV Partners and Unilazer Ventures will contribute Rs 7 crore and Rs 8.6 crore, respectively. The company plans to deploy the funds toward expansion and overall business growth. According to Entrackr’s estimates, the fresh funding will value the company at a post-money valuation of around Rs 150 crore ($17 million). Following this transaction, Peak XV Partners will command a 20.77% stake, while Kae Capital and Unilazer Ventures will own 11.97% and 5.69%, respectively. Meanwhile, Grapevine’s co-founders, Jainam Dinesh Talsania, Shreeyash Nitin Dharmadhikari, and Saumil Sanjai Tripathi, will collectively retain 48.78% ownership in the company. Prior to this round, Grapevine had raised $2.6 million in its seed round, led by Peak XV Partners, which had picked up a little over 20% stake at the time. Entrackr had exclusively reported that development as well. Founded in early 2023, Grapevine enables unrestricted and anonymous discussions across topics such as career, finance, professional experiences, and personal matters. The platform claims to have a thriving community of over 30,000 members, largely comprising professionals from tech companies and startups. The company competes to an extent with FishBowl, Blind, Together, and Reddit, all of which operate in the anonymous professional networking and discussion space.

Exclusive: Ambak starts Series A round with Rs 69 Cr funding led by Peak XV and Z47

EntrackrEntrackr · 3d ago
Exclusive:  Ambak starts Series A round with Rs 69 Cr funding led by Peak XV and Z47
Medial

**Exclusive: Ambak starts Series A round with Rs 69 Cr funding led by Peak XV and Z47** Home loan startup Ambak has kicked off its Series A round with Rs 69 crore (approximately $7.84 million) co-led by existing backers Peak XV Partners and Z47 (formerly Matrix Partners) with the participation of DeVC and others. This comes after the company announced $7 million in funding in January 2025 through a combination of Seed and Pre-Series A rounds led by Peak XV Partners. According to its regulatory filing with the RoC, Ambak’s board has issued 3,111 Series A CCPS and 10 equity shares at an issuance price of Rs 2,20,405.6 per share to raise the above-mentioned amount. Peak XV Partners and Z47 co-led the tranche with Rs 26.62 crore or $3 million each, followed by DeVC India and Advantage Technology Fund who invested Rs 6.65 crore and Rs 6.28 crore respectively. Calabasas Ventures, AngelList, Sushmita Mathur, Ojaswa Sharma, Anil Kumar Goteti, and others contributed the remaining amount. According to Entrackr’s analysis, the company’s valuation has surged by over 76% to Rs 450 crore ($51 million) post-money, compared with its Rs 255 crore valuation in the previous round. Founded in 2023, Ambak streamlines the home loan process through a transparent three-step system that matches customers with the right financiers using Digital Public Infrastructure (DPI) and bank rule engines. Its tech-driven, assisted model simplifies workflows for both borrowers and lending partners. Following the latest infusion, Peak XV remains the largest external shareholder with a 14.9% stake, followed by Surge Ventures and Z47 at 13.95% and 6.25% respectively. The co-founders Raghuveer Malik, Rameshwar Gupta, and Rashi Garg collectively hold 46.23% of the company, according to TheKredible. In its first year of operations, Ambak reported Rs 1.03 crore in operating revenue for the fiscal year ended March 2024 and a loss of Rs 2.11 crore. The company has not yet disclosed its FY25 figures. Last year, several other home finance startups also raised funding, including Easy Home Finance, which secured $35 million led by Ranjan Pai’s family office and Claypond Capital, and Basic Home Loan, which raised $10.6 million, among others.

Exclusive: Peak XV joins Truemeds’ Series C round with $20 Mn

EntrackrEntrackr · 4m ago
Exclusive: Peak XV joins Truemeds’ Series C round with $20 Mn
Medial

Exclusive: Peak XV joins Truemeds’ Series C round with $20 Mn Telehealth platform Truemeds has secured another $20 million or Rs 174.33 crore in its ongoing Series C round from new investor Peak XV Partners. This investment is an extension of the $44 million raised by Truemeds in March this year, led by Accel, which was exclusively reported by Entrackr. The board at Truemeds has allotted 19,737 Series C2 compulsory convertible preference shares at an issue price of Rs 88,331 each to raise the aforementioned sum from Peak XV, its regulatory filing accessed from the Registrar of Companies (RoC) shows. The company plans to utilise the funds for business expansion and to support its growth plans, according to the filing. As per Entrackr’s estimates, its valuation stood at $410 million (Rs 3,487 crore) in the new tranche (post-allotment), a 22% increase from its C1 tranche. Founded by Naitik Nayyar and Akshat Wani, Truemeds helps consumers discover cost-effective alternative brands for prescribed medicines by analyzing the prescriptions they upload. It partners with certified pharmacies to deliver medicines at discounted prices, aiming to make healthcare more affordable and accessible. According to startup data intelligence platform TheKredible, the firm has raised over $90 million to date. Following the latest allotment, Peak XV holds a 5% stake in the company. Westbridge is the largest shareholder in Truemeds followed by Info Edge which owns 21.87% stake. Co-founders Naitik Nayyar and Akshat Wani both collectively retain 21.3%. Truemeds doubled its revenue to Rs 315 crore in FY24, while its losses narrowed by 9% to Rs 61 crore during the same period. The Mumbai-based firm competes with telehealth platforms like PharmEasy, which recorded Rs 5,664 crore in revenue in FY24, and Tata 1mg, which posted Rs 1,964 crore.

Download the medial app to read full posts, comements and news.